Ingredient
Melilotus Officinalis Herb Extract
Melilotus Officinalis Herb Extract is flagged for pregnancy. The concern behind the strongest flag is absorbed into the body.
- Sweet Clover Extract
- Yellow Sweet Clover Extract
- Melilot Extract
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 1 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Melilotus Officinalis Herb Extract and pregnancy
Caution Advised
- Absorbed into the body
Melilotus Officinalis Extract comes from sweet clover and contains coumarins, compounds that have anticoagulant properties similar to warfarin. While primarily used for fragrance in cosmetics, the extract's coumarin content raises theoretical concerns during pregnancy. Oral consumption of sweet clover or coumarin-containing supplements is contraindicated during pregnancy due to potential bleeding risks and possible effects on fetal development. While topical absorption from cosmetic products is significantly lower than oral intake, coumarins can penetrate the skin and enter systemic circulation. There is limited specific data on topical sweet clover extract safety during pregnancy. Given the known anticoagulant properties of coumarins and their potential to cross the placenta, many healthcare providers recommend caution with coumarin-containing botanicals during pregnancy. Due to the theoretical bleeding risk associated with coumarin absorption and insufficient safety data for topical use during pregnancy, pregnant women may choose to avoid products containing Melilotus Officinalis Extract. While the risk from cosmetic use is likely lower than from oral consumption, the lack of comprehensive safety studies and the ingredient's known bioactivity warrant a precautionary approach.
Melilotus Officinalis Herb Extract and breastfeeding
Safe to Use
Melilotus Officinalis Extract contains coumarins, which have anticoagulant properties. While oral sweet clover products are cautioned against during breastfeeding due to potential effects on infant bleeding risk, topical cosmetic use represents much lower exposure. There is limited data on coumarin transfer into breast milk following topical application of sweet clover extract in cosmetics. The amounts absorbed through skin from cosmetic products are substantially lower than oral therapeutic doses. No adverse effects in breastfed infants have been reported from maternal topical use of sweet clover extract in cosmetics. Breastfeeding women can generally use cosmetic products containing sweet clover extract with caution. The low concentration in cosmetics and minimal systemic absorption suggest low risk. However, women with bleeding disorders or infants with clotting issues should consult healthcare providers. Avoid applying products to the breast area before breastfeeding.
Melilotus Officinalis Herb Extract and postpartum
Safe to Use
- Common allergen
Melilotus Officinalis Extract can be used during the postpartum period by women who are not breastfeeding. The main consideration is the potential for allergic reactions in sensitive individuals and theoretical concerns about coumarin content in those with bleeding disorders. For postpartum women not breastfeeding, there are minimal specific concerns beyond general cautions about coumarin-containing botanicals. Women who had bleeding complications during delivery or have clotting disorders should consult their healthcare provider before using products with sweet clover extract, though topical cosmetic use poses low risk.
Melilotus Officinalis Herb Extract and trying to conceive
Safe to Use
Melilotus Officinalis Extract does not have established effects on fertility when used topically in cosmetic products. The coumarin content does not directly impact reproductive hormones or conception in the concentrations used in cosmetics. Women trying to conceive can generally use cosmetic products containing sweet clover extract. However, since recommendations for pregnancy suggest caution with this ingredient, some women may choose to avoid it during the preconception period as well. This is a personal choice based on individual risk tolerance rather than evidence of fertility effects.
Melilotus Officinalis Herb Extract and PCOS
Safe to Use
Melilotus Officinalis Extract does not have known hormonal effects relevant to PCOS. The extract's primary bioactive compounds are coumarins, which have anti-inflammatory and venotonic properties but do not directly affect androgen or insulin pathways. There are no specific PCOS-related concerns with topical use of sweet clover extract in cosmetics. The anti-inflammatory properties may provide minor benefits for inflammatory skin conditions, though evidence is limited. Women with PCOS can safely use cosmetic products containing Melilotus Officinalis Extract. The ingredient does not interfere with hormonal balance, insulin sensitivity, or PCOS medications. Individual tolerance and potential for allergic reactions are the main considerations.
Melilotus Officinalis Herb Extract and general use
Safe to Use
- Common allergen
- Increases sun sensitivity
Melilotus Officinalis Extract is used in cosmetics for fragrance and potential anti-inflammatory benefits. The extract contains coumarins, which provide the characteristic sweet scent but can also cause allergic reactions in sensitive individuals. The main concern for general use is allergen potential, particularly in individuals sensitive to coumarin-containing plants. Some coumarins can increase photosensitivity, so sun protection is advisable when using products containing this extract. People taking anticoagulant medications should be aware of the ingredient's presence, though topical cosmetic use is unlikely to cause clinically significant interactions. Sweet clover extract is permitted in cosmetics under EU and US regulations. The EU requires labeling of coumarin when present above certain concentrations due to allergen potential. Overall, the ingredient has a relatively safe profile for topical use in the general population when properly formulated.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Melilotus Officinalis Herb Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store